Subarachnoid hemorrhage (SAH) due to intracranial aneurysm rupture is a complex clinical disease with high mortality and morbidity. Recent studies suggest that early brain injury (EBI) rather than vasospasm might be responsible for morbidity and mortality within 24-72 hours after SAH. The rise in intracranial pressure following SAH causes a significant drop in cerebral perfusion pressure that leads to global cerebral ischemia and initiates the acute injury cascade. Various molecular mechanisms have been shown to involve in the pathophysiology of EBI including cellular apoptosis. In this review, we summarize apoptotic molecular mechanisms involved in the etiology of EBI and its potential as a target for future therapeutic intervention.
InTRoduCTIon
Each year approximately 10 out of 100,000 people experience a subarachnoid hemorrhage (SAH) due to intracranial aneurysm rupture (26, 28) . Despite the recent developments in microsurgical and endovascular surgical techniques, the prognosis for patients who suffer a SAH remains unsatisfactory. SAH is a complex clinical disease that is often associated with many interrelated complications such as cerebral edema, obstructive hydrocephalus, diffuse/focal cerebral ischemia or infarction (35) .
A common complication of SAH is vasospasm, which is still a leading cause of morbidity and mortality in patients with ruptured aneurysms that may occur 3-14 days following a SAH. Angiographic evidence of vasospasm is seen in up to 70% of patients, and 20 to 30% of patient's manifest neurological deficits (14, 24) . Vasospasm has been the focus of the majority of experimental and clinical research efforts during the past number of decades. Several types of treatment strategies such as circulatory volume expansion, statins, and magnesium sulfate and calcium antagonists have been studied in clinical trials to prevent or reverse vasospasm (12, 34, 36, 43) . Based on the current evidence, only oral nimodipine is recommended as a standard treatment in patients with aneurysmal SAH (34) . However, the reversal of vasospasm does not appear to improve outcome alone.
Delayed ischemic neurological deficits (DIND) due to vasospasm are rare within 3 days of SAH. Hence, the major causes of death within 72 hours following a SAH are the effects of the initial hemorrhage and aneurysmal rebleeding (4). A recently described concept early brain injury (EBI) looks at overall brain injury after SAH (5-7). Growing evidences have suggested that EBI, which occurs during the 24-72 h following aneurysm rupture, largely contributes to unfavorable outcome (33) . In this review, we summarize the current knowledge on 
Early Brain Injury
EBI is a term used to explain the pathophysiology that occurs within the brain after a SAH within the first 72 hours of the ictus. To date, both theoretically and clinically, this area has been neglected in favor of vasospasm, which typically occurs after the initial 72 hours. In addition, EBI challenges the already tenuous link between vasospasm and DIND. Although unproven, it can be suggested that EBI is a precursor for both DIND and vasospasm, which occur in parallel with each other and do not have a cause and effect relationship.
EBI is believed to arise from the significant pathophysiological mechanisms, which occur in the brain at the moment of a SAH.
The initial blood load causes an increase in the intracranial pressure (ICP), which has been demonstrated in both human and animal models. The quantity of the initial blood load drives the degree of the ICP rise. As the pressure rises the cerebral perfusion pressure (CPP) falls. The mechanism behind this relationship is imprisely understood, although it is believed to be related to the Monroe-Kelly hypothesis, furthermore both vasoparalysis and cerebrospinal fluid obstruction have also been implicated. The rise in the ICP and subsequent fall in the CPP result in a significant drop in the cerebral blood flow, which can in experimental studies drop to zero. While this is a transitory fall, the consequences are significant in both long and short term (Figure 1 ). These physiological derangements result in blood brain barrier dysfunction, inflammation, and oxidative cascades that lead to neuronal cell death (2) ( Figure  2 ). 
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These events result in a global ischemic injury, which varies in severity. Clearly in the most severe form the degree of ischemia is prolonged and results in death. This has been seen in post mortem studies where necrosis can be demonstrated throughout the brain. This occurs in about 30% of patients. In the remainder the degree of ischemia is not as severe and both apoptosis and to a lesser degree necrosis is evident. In grade one patients following a SAH, the degree of injury is more subtle and is believed to be limited to apoptosis in more sensitive areas of the brain, for example the hippocampus. This has been demonstrated in both animal models and in patients post mortem (30, 31, 44, 46, 47) .
Apoptosis in EBI
Apoptosis is not a new concept, yet the complex and intricately interwoven pathways are still being elucidated. In addition, it appears that different pathways are important depending on the initial insult. For example, it has been shown that the caspase dependent cascade may be particularly important in relation to ischemia while the caspase independent cascade relates more to neurotoxin induced apoptosis (11) . There are a number of pathways that are believed to be important in relation to SAH; these include the death receptor pathway, p53, the caspase dependent and independent pathways and the mitochondrial pathway (6, 8, 23).
SAH has been referred to as an external stress event which through a mechanism that is not fully understood (27) can initiate cellular apoptosis (23, 25) . Apoptotic cell death may be seen in both cortical, subcortical or hippocampal neurons and endothelium following SAH. It can be initiated through a variety of mechanisms including global ischemia due to increased ICP, microcirculatory disturbance, and subarachnoid blood toxicity (23) . However, intracellular signaling pathways that are involved in mediating the apoptosis have not been fully investigated. Matrix metalloproteinase-9 (MMP-9), a member of endopeptidase family, can mediate apoptosis through cleaving main components of the extracellular matrix. The activity of MMP-9 and its substrate, laminin, are significantly altered in hippocampus following SAH in rats (21) . Mitogen-activated protein kinases including extracellular signal-regulated kinase, c-Jun N-terminal kinase (JNK), and p38 were reported to induce apoptosis in the brain and cerebral artery after SAH. It has been also shown that there is a link between JNK, MMP-9 and caspase-3 activation following SAH. JNK not only induces a variety of proapoptotic proteins, such as c-Jun, p53, bim, and bax, but also inhibits anti-apoptotic proteins including Bcl-2 and Bcl-xl (40) . However, activation of phosphoinositide 3-kinase / Akt (protein kinase B) pathway exerts anti-apoptotic properties by decreasing activation of proapoptotic caspases (15, 17, 22) .
It is believed that the death receptors within the cell membrane may be responsible for apoptotic cascade following SAH. There are a number of receptors that have been examined including Fas, TNFR1 and DR3-5 that may be responsible for the translation of the signal across the cell membrane and the activation of the TNFR family. In particular, TNF-α and Fas have been shown to upregulate after a SAH (44, 45) . These death receptors have been shown to be capable of activating the caspase cascades through a number of mechanisms (16) . One of the most important mechanisms is the ability of the death receptors to stabilize p53 in the cytosol. Additional experimental studies examining the effects of pancaspase inhibitors have shown a favorable outcome with regard to SAH, suggesting that p53 may work through either the caspase dependent or mitochondrial pathway in SAH induced apoptosis (31, 45) .
P53 has been shown to be an orchestrating protein in the apoptotic pathways following a SAH (5-7). P53 is stabilized in the cytosol, which occurs through phosphorylation and occurs in response to any significant stress event including SAH (18) . Once this occurs p53 activates the mitochondrial apoptotic pathway through the Bcl-2 family of proteins, which are divided into both pro and anti-apoptotic members (19) . Therefore, the Bcl-2 family can either stimulate or inhibit cytochrome C release from mitochondria depending on the dominant signal, i.e. pro or anti-apoptotic dominance (32). It is important to realize that apoptosis is not an all or none mechanism (38) . P53 acting independently of the Bcl-2 family can also initiate the caspase cascades through its action on procaspase 8, which is cleaved to form caspase 8 which in turn cleaves Bid to form truncated Bid (tBid). tBid then permits the release of cytochrome C from mitochondria which is further regulated by Bcl-2 and Bcl-x L (37). Once released, Cytochrome C combines with Apaf-1 to form the apoptosome, which in turn recruits and cleaves procaspase 9, thereby activating the caspase cascade (29) .
As mentioned, the apoptotic cascades can involve the intrinsic or mitochondrial pathway and the extrinsic pathway. The subsequent cascade, which the cell embarks upon, appears to be regulated, at least in part, by the availability of ATP. The mitochondrial pathway is energy dependent and occurs for example in the penumbra (3), where energy is still available. In ATP depleted areas, the extrinsic pathway, i.e. caspase 8, which is capable of self-cleavage, with direct activation of caspase 3, occurs. Hippocampal cells are far more prone to injury compared to other areas due to their sensitivity to ischemia as a result of high ATP requirements (31). Caspase 8 was also shown to decrease in experimental models of SAH induced apoptosis after the prevention of p53 stabilization in the cytosol, suggesting that the caspase dependent and mitochondrial release of cytochrome C are important in SAH (5-7). The importance of the apoptotic cascades has been shown to be significant not only within the brain parenchyma but also within the cerebral vasculature. It has been shown that apoptosis occurs in the endothelial cells of vessels, the prevention of which can attenuate the degree of vasospasm (45) . Apoptosis has been identified in a patient who died from a SAH (46) .
Experimental models of stroke and SAH have shown that the inhibition of caspases can offer some protection, however apoptosis still occurs (31, 42, 45) . Therefore, it seems clear that another caspase independent cascade may be involved. Apoptosis inducing factor (AIF) has been shown to be released from the mitochondria and translocate to the nucleus in response to various death signals (9, 10) . P53 has been shown to trigger the release of AIF in the absence of Apaf-1 resulting in a caspase independent apoptotic cascade (9) . Interestingly in a similar way to cytochrome C, AIF appears to be under the control of the Bcl-2 family and in fact the release of both AIF and cytochrome C are inhibited if Bcl-2 members are blocked, suggesting that the Bcl-2 family may be solely responsible for the caspase dependent and independent cascades (9, 41). The Bcl-2 family is also responsible for the inhibition of second mitochondria derived activator of caspase/direct IAP binding protein with low pI (Smac/Diablo) (13, 39 ), yet another mitochondrial protein similar to cytochrome C, which depresses procaspase-9 through the inhibition of inhibitor of apoptosis protein-1. This makes the Bcl-2 family a powerful target for future therapeutic intervention.
ConCluSIon
Much progress has been made toward understanding the mechanisms of EBI following SAH. As evidenced by the number of publications, apoptosis plays a significant role in EBI, thereby could be a therapeutic target after SAH. However, much more work will be required to fully characterize the molecular signaling pathways regulating apoptosis in EBI. 
